753922-19-9 Usage
Derivative of indazole
A heterocyclic aromatic organic compound based on the core structure of indazole, with modifications in its side chains or substituents.
Indazole ring
A five-membered aromatic ring with three carbon atoms and two nitrogen atoms, providing the basis for the compound's structure.
Ethyl group at the 3-position
A two-carbon side chain (CH3-CH2) attached to the indazole ring at the third carbon atom, which influences the compound's properties and reactivity.
6-[(4-fluorophenyl)thio] group
A substituent containing a sulfur atom connected to a fluorine-substituted phenyl ring at the 6-position of the indazole, further modifying the compound's properties.
Fluorine substitution on phenyl ring
The presence of a fluorine atom on the phenyl ring, which can affect the compound's electronic properties and reactivity.
Potential applications in pharmaceutical or research settings
The compound may have uses in the development of new drugs or as a research tool in scientific studies due to its unique structure and properties.
Subject of scientific study
The properties and behavior of 1H-Indazole, 3-ethyl-6-[(4-fluorophenyl)thio]may be investigated to better understand its potential applications and interactions with biological systems.
Check Digit Verification of cas no
The CAS Registry Mumber 753922-19-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,5,3,9,2 and 2 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 753922-19:
(8*7)+(7*5)+(6*3)+(5*9)+(4*2)+(3*2)+(2*1)+(1*9)=179
179 % 10 = 9
So 753922-19-9 is a valid CAS Registry Number.
753922-19-9Relevant academic research and scientific papers
P38 inhibitors and methods of use thereof
-
Page/Page column 22; sheet 14, (2008/06/13)
This invention relates to inhibitors of p38, and methods for producing these inhibitors. The invention also provides pharmaceutical compositions comprising the inhibitors of the invention and methods of utilizing the inhibitors and pharmaceutical compositions in the treatment and prevention of various disorders mediated by p38.
